Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Postural Orthostatic Tachycardia Syndrome in Women

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Big Heads & Small Heads

Peanut Allergy

expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland